Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers

被引:128
作者
Cullinane, CA
Lubinski, J
Neuhausen, SL
Ghadirian, P
Lynch, HT
Isaacs, C
Weber, B
Moller, P
Offit, K
Kim-Sing, C
Friedman, E
Randall, S
Pasini, B
Ainsworth, P
Gershoni-Baruch, R
Foulkes, WD
Klijn, J
Tung, N
Rennert, G
Olopade, O
Couch, F
Wagner, T
Olsson, H
Sun, P
Weitzel, JN
Narod, SA
机构
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada
[3] Pomeranian Med Univ, Szczecin, Poland
[4] Univ Calif Irvine, Div Epidemiol, Ctr Canc Genet Res & Prevent, Coll Med, Irvine, CA USA
[5] Univ Montreal, Hotel Dieu, Epidemiol Res Unit, CHU Montreal, Montreal, PQ, Canada
[6] Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA
[7] Georgetown Univ, Lombardi Canc Ctr, Med Ctr, Washington, DC USA
[8] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[9] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
[10] Norwegian Radium Hosp, Dept Canc Genet, Oslo, Norway
[11] Mem Sloan Kettering Canc Ctr, Dept Human Genet & Med, New York, NY 10021 USA
[12] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[13] Chaim Sheba Med Ctr, Oncogenet Unit, IL-52621 Tel Hashomer, Israel
[14] Princess Margaret Hosp, Dept Gynecol Oncol, Toronto, ON M4X 1K9, Canada
[15] Univ Turin, Genet Sect, Turin, Italy
[16] London Hlth Sci Ctr, London, ON, Canada
[17] Rambam Med Ctr, Inst Genet, Haifa, Israel
[18] McGill Univ, Program Canc Genet, Dept Oncol & Human Genet, Montreal, PQ, Canada
[19] Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands
[20] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[21] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[22] Carmel Hosp, Natl Canc Control Ctr, Haifa, Israel
[23] Univ Chicago, Ctr Clin Canc Genet, Chicago, IL 60637 USA
[24] Mayo Clin, Rochester, MN USA
[25] Med Univ Vienna, Div Senol, Dept Obstet & Gynecol, Vienna, Austria
[26] Private Trust Breast Hlth, Vienna, Austria
[27] Univ Lund Hosp, Jubileum Inst, Dept Oncol, S-22185 Lund, Sweden
关键词
parity; breast cancer; BRCA mutation;
D O I
10.1002/ijc.21273
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Early age at first birth and multiparity have been associated with a decrease in the risk of breast cancer in women in the general population. We examined whether this relationship is also present in women at high risk of breast cancer due to the presence of a mutation in either of the 2 breast cancer susceptibility genes, BRCA1 or BRCA2. We performed a matched case-control study of 1,260 pairs of women with known BRCA1 or BRCA2 mutations, recruited from North America, Europe and Israel. Women who had been diagnosed with breast cancer were matched with unaffected control subjects for year of birth, country of residence, and mutation (BRCA1 or BRCA2). Study subjects completed a questionnaire detailing their reproductive histories. Odds ratios (ORs) and 95% confidence intervals (CIs) were derived by conditional logistic regression. Among BRCA1 carriers, parity per se was not associated with the risk of breast cancer (OR for parous vs. nulliparous = 0.94; 95% CI = 0.75-1.19; p = 0.62). However, women with a BRCA1 mutation and 4 or more children had a 38% decrease in breast cancer risk compared to nulliparous women (OR = 0.62; 95% CI = 0.41-0.94). In contrast, among BRCA2 carriers, increasing parity was associated with an increased risk of breast cancer; women with 2 or more children were at approximately 1.5 times the risk of breast cancer as nulliparous women (OR = 1.53; 95% CI = 1.01-2.32; p = 0.05). Among women with BRCA2 mutations and who were younger than age 50, the (adjusted) risk of breast cancer increased by 17% with each additional birth (OR = 1.17; 95% CI = 1.01-1.36; p = 0.03). There was no significant increase in the risk of breast cancer among BRCA2 carriers older than 50 (OR for each additional birth 0.97; 95% CI = 0.58-1.53; p = 0.92). In the 2-year period following a birth, the risk of breast cancer in a BRCA2 carrier was increased by 70% compared to nulliparous controls (OR = 1.70; 95% CI = 0.97-3.0). There was a much smaller increase in breast cancer risk among BRCA2 carriers whose last birth was 5 or more years in the past (OR = 1.24; 95% CI = 0.79-1.95). A modest reduction in risk of breast cancer was observed among BRCA1 carriers with 4 or more births. Among BRCA2 carriers, increasing parity was associated with a significant increase in the risk of breast cancer before age 50 and this increase was greatest in the 2-year period following a pregnancy. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:988 / 991
页数:4
相关论文
共 12 条
[1]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[2]  
Chie WC, 2000, AM J EPIDEMIOL, V151, P715, DOI 10.1093/oxfordjournals.aje.a010266
[3]   AGE AT 1ST BIRTH, PARITY AND RISK OF BREAST-CANCER - A METAANALYSIS OF 8 STUDIES FROM THE NORDIC COUNTRIES [J].
EWERTZ, M ;
DUFFY, SW ;
ADAMI, HO ;
KVALE, G ;
LUND, E ;
MEIRIK, O ;
MELLEMGAARD, A ;
SOINI, I ;
TULINIUS, H .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (04) :597-603
[4]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[5]  
Gemignani Mary L., 2000, Breast J, V6, P68, DOI 10.1046/j.1524-4741.2000.99039.x
[6]  
JEMSTROM H, 1999, LANCET, V354, P1846
[7]   Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers [J].
Jernström, H ;
Lubinski, J ;
Lynch, HT ;
Ghadirian, P ;
Neuhausen, S ;
Isaacs, C ;
Weber, BL ;
Horsman, D ;
Rosen, B ;
Foulkes, WD ;
Friedman, E ;
Gershoni-Baruch, R ;
Ainsworth, P ;
Daly, M ;
Garber, J ;
Olsson, H ;
Sun, P ;
Narod, SA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (14) :1094-1098
[8]   Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers [J].
Johannsson, O ;
Loman, N ;
Borg, Å ;
Olsson, H .
LANCET, 1998, 352 (9137) :1359-1360
[9]   BREAST-CANCER IN SWEDISH WOMEN BEFORE AGE 50 - EVIDENCE OF A DUAL EFFECT OF COMPLETED PREGNANCY [J].
LEON, DA ;
CARPENTER, LM ;
BROEDERS, MJM ;
GUNNARSKOG, J ;
MURPHY, MFG .
CANCER CAUSES & CONTROL, 1995, 6 (04) :283-291
[10]   Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden) [J].
Liu, Q ;
Wuu, J ;
Lambe, M ;
Hsieh, SF ;
Ekbom, A ;
Hsieh, CC .
CANCER CAUSES & CONTROL, 2002, 13 (04) :299-305